Consultation record
Submissions noted, no amendment — page 3
The submission raises a point the Institute accepts but that does not require a change to the draft, most often because the draft already states it elsewhere. The location is given in the response.
Submissions
127 documents · page 3 of 5
Table 1. Submissions with this disposition, on this page.
| Reference | Consultation | Respondent | Point raised |
|---|---|---|---|
| DRAFT-AMYCRETIN-MO/010 | Draft monograph: amycretin | Dr Eamon Immelmann | The monograph should not describe how the compound is supplied outside a regulated route |
| DRAFT-AMYCRETIN-MO/001 | Draft monograph: amycretin | Dr Marisol Dunmore-Ekpo | Guidance on lyophilised storage is missing |
| DRAFT-AMYCRETIN-MO/012 | Draft monograph: amycretin | Dr Melisande Thorsby-Nakamura | A superseded version should remain reachable from the version that replaced it |
| DRAFT-AOD-9604-MON/013 | Draft monograph: AOD-9604 | Dr Quintus Rautavaara | A sortable table implies a comparison the underlying data do not support |
| DRAFT-AOD-9604-MON/015 | Draft monograph: AOD-9604 | Dr Rurik Haverkamp-Diallo | Guidance on lyophilised storage is missing |
| DRAFT-AOD-9604-MON/005 | Draft monograph: AOD-9604 | Dr Ursina Ellsworth-Vance | The monograph should not describe how the compound is supplied outside a regulated route |
| DRAFT-CAGRILINTIDE/012 | Draft monograph: Cagrilintide | Dr Quintus Kettlewell | A sortable table implies a comparison the underlying data do not support |
| DRAFT-CAGRISEMA-MO/002 | Draft monograph: CagriSema (cagrilintide with semaglutide) | Dr Quentin Enthoven | The monograph should not describe how the compound is supplied outside a regulated route |
| DRAFT-CJC-1295-MON/002 | Draft monograph: CJC-1295 | Dr Theodora Trelawney | The monograph should not describe how the compound is supplied outside a regulated route |
| DRAFT-ECNOGLUTIDE-/006 | Draft monograph: Ecnoglutide | Yusuf Whitmarsh-Obi | A sortable table implies a comparison the underlying data do not support |
| DRAFT-ECNOGLUTIDE-/005 | Draft monograph: Ecnoglutide | Dr Amara Quaresma | Declared interests should appear on the document rather than on a separate page |
| DRAFT-GHRP-2-MONOG/002 | Draft monograph: GHRP-2 | Gaspard Kettlewell | Declared interests should appear on the document rather than on a separate page |
| DRAFT-GHRP-2-MONOG/001 | Draft monograph: GHRP-2 | Valentin Tollemache | A sortable table implies a comparison the underlying data do not support |
| DRAFT-GHRP-2-MONOG/004 | Draft monograph: GHRP-2 | Professor Bartolomeu Nkosi-Lindegaard | The monograph should not describe how the compound is supplied outside a regulated route |
| DRAFT-GLUTATHIONE-/014 | Draft monograph: Glutathione | Dr Amara Vandergraaf | A superseded version should remain reachable from the version that replaced it |
| DRAFT-GONADORELIN-/009 | Draft monograph: Gonadorelin | Dr Frideswide Hazelrigg | A superseded version should remain reachable from the version that replaced it |
| DRAFT-IGF-1-LR3-MO/001 | Draft monograph: IGF-1 LR3 | Dr Anselm Thorsby-Nakamura | A superseded version should remain reachable from the version that replaced it |
| DRAFT-IPAMORELIN-M/010 | Draft monograph: Ipamorelin | Professor Chukwuemeka Rasmussen-Adeyemi | The monograph should not describe how the compound is supplied outside a regulated route |
| DRAFT-KISSPEPTIN-1/003 | Draft monograph: Kisspeptin-10 | Ms Rhiannon Okoye-Vandergraaf | Guidance on lyophilised storage is missing |
| DRAFT-KPV-MONOGRAP/010 | Draft monograph: KPV | Dr Wolfram Tollemache | A superseded version should remain reachable from the version that replaced it |
| DRAFT-KPV-MONOGRAP/013 | Draft monograph: KPV | Dr Oisín Marchetti-Bassey | A sortable table implies a comparison the underlying data do not support |
| DRAFT-LL-37-MONOGR/006 | Draft monograph: LL-37 | Dr Marisol Dunmore-Ekpo | Guidance on lyophilised storage is missing |
| DRAFT-MARIDEBART-C/006 | Draft monograph: Maridebart cafraglutide | Dr Séverine Oduya-Kaltenbrunner | Guidance on lyophilised storage is missing |
| DRAFT-MOTS-C-MONOG/007 | Draft monograph: MOTS-c | Dr Wilhelmina Oppenheimer-Ade | The monograph should not describe how the compound is supplied outside a regulated route |
| DRAFT-ORAL-SEMAGLU/001 | Draft monograph: Semaglutide, oral | Dr Fenella Steenkamp-Ferreira | Declared interests should appear on the document rather than on a separate page |
| DRAFT-PRAMLINTIDE-/006 | Draft monograph: Pramlintide | Dr Stellan Cholmondeley-Ade | Declared interests should appear on the document rather than on a separate page |
| DRAFT-PT-141-MONOG/010 | Draft monograph: PT-141 (bremelanotide) | Vittoria Quintanilha | Guidance on lyophilised storage is missing |
| DRAFT-SELANK-MONOG/003 | Draft monograph: Selank | Dr Mordecai Bellingham-Ojo | A sortable table implies a comparison the underlying data do not support |
| DRAFT-SEMAX-MONOGR/006 | Draft monograph: Semax | Dr Odalys Thorsby-Nakamura | Guidance on lyophilised storage is missing |
| DRAFT-SEMAX-MONOGR/008 | Draft monograph: Semax | Dr Wilhelmina Oppenheimer-Ade | A sortable table implies a comparison the underlying data do not support |
page 3 of 5